Cytoreductive surgery and intraperitoneal chemohyperthermia for chemoresistant and recurrent advanced epithelial ovarian cancer: Prospective study of 81 patients

World Journal of Surgery

Volumn 31, Issue 9, 2007, Pages 1813-1820

  Cotte, Eddy ^a,b   Glehen, Olivier ^a,b   Mohamed, Faheez ^c   Lamy, Franck ^a,b   Falandry, Claire ^a,b   Golfier, François ^a,b   Gilly, Francois Noel ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ CLAUDE BERNARD LYON 1   (France)

^c Faculty of Medical Sciences   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMATOSIS; CLINICAL TRIAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OVARY CANCER; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; INJECTIONS, INTRAPERITONEAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS;

EID: 34548009798     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9146-8     Document Type: Article

References (36)

1. Bonnefoi H, A'Hern RP, Fisher C, et al. (1999) Natural history of stage IV epithelial ovarian cancer. J Clin Oncol 17:767-775
2. Randall TC, Rubin SC (2001) Cytoreductive surgery for ovarian cancer. Surg Clin North Am 81:871-883
3. Bristow RE, Tomacruz RS, Armstrong DK, et al. (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248-1259
4. Griffiths CT (1975) Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 42:101-104
5. Zang RY, Zhang ZY, Li ZT, et al. (2000) Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer. J Surg Oncol 75:24-30
6. Glehen O KF, Sugarbaker PH, Elias D, et al. (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284-3292
7. Rose PG, Nerenstone S, Brady MF, et al. (2004) Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med 351:2489-2497
8. Panteix G, Beaujard A, Garbit F, et al. (2002) Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy. Anticancer Res 22:1329-1336
9. Gilly FN, Carry PY, Sayag AC, et al. (1994) Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41:124-129
10. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359-374
11. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29-42
12. Glehen O, Mithieux F, Osinsky D, et al. (2003) Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol 21:799-806
13. Markman M, Reichman B, Hakes T, et al. (1991) Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin. J Clin Oncol 9:1801-1805
14. Onda T, Yoshikawa H, Yasugi T, et al. (2005) Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection. Br J Cancer 92:1026-1032
15. van der Vange N, van Goethem AR, Zoetmulder FA, et al. (2000) Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot. Eur J Surg Oncol 26:663-668
16. Glehen O, Beaujard AC, Arvieux C, et al. (2002) Les carcinoses péritonéales: traitement chirurgical, péritonectomie et chimiohyperthermie intrapéritonéale [Peritoneal carcinomatosis: surgical treatment, peritonectomy and intraperitoneal chemohyperthermia]. Gastroenterol Clin Biol 26:210-215
17. Crile G Jr (1963) The effects of heat and radiation on cancers implanted on the feet of mice. Cancer Res 23:372-380
18. Barlogie B, Corry PM, Drewinko B (1980) In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum (II) and mitomycin C. Cancer Res 40:1165-1168
19. Glehen O, Mohamed F, Gilly FN (2004) Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5:219-228
20. Elias DM, Ouellet JF (2001) Intraperitoneal chemohyperthermia: rationale, technique, indications, and results. Surg Oncol Clin N Am 10:915-933, xi
21. de Bree E, Romanos J, Michalakis J, et al. (2003) Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin. Anticancer Res 23:3019-3027
22. Look M, Chang D, Sugarbaker PH (2003) Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 13:764-770
23. Deraco M, Rossi CR, Pennacchioli E, et al. (2001) Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study. Tumori 87:120-126
24. Zanon C, Clara R, Chiappino I, et al. (2004) Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg 28:1040-1045
25. Piso P, Dahlke MH, Loss M, et al. (2004) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer. World J Surg Oncol 2:21
26. Plaisant N, Quenet F, Fabbro M, et al. (2004) Secondary debulking surgery and intraperitoneal chemotherapy in advanced or recurrent epithelial ovarian cancer. Gynecol Obstet Fertil 32:391-397
27. Vaccarello L, Rubin SC, Vlamis V, et al. (1995) Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol 57:61-65
28. Cormio G, di Vagno G, Cazzolla A, et al. (1999) Surgical treatment of recurrent ovarian cancer: report of 21 cases and a review of the literature. Eur J Obstet Gynecol Reprod Biol 86:185-188
29. Gadducci A, Iacconi P, Cosio S, et al. (2000) Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol Oncol 79:344-349
30. Eisenkop SM, Friedman RL, Spirtos NM (2000) The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 88:144-153
31. Scarabelli C, Gallo A, Carbone A (2001) Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol 83:504-512
32. Tay EH, Grant PT, Gebski V, et al. (2002) Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Obstet Gynecol 99:1008-1013
33. Kusamura S, Younan R, Baratti D, et al. (2006) Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 106:1144-1153
34. Munkarah AR, Coleman RL (2004) Critical evaluation of secondary cytoreduction in recurrent ovarian cancer. Gynecol Oncol 95:273-280
35. Barakat RR, Sabbatini P, Bhaskaran D, et al. (2002) Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up. J Clin Oncol 20:694-698
36. Armstrong DK, Bundy B, Wenzel L, et al. (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34-43